PeptideStack
5.2kquestions
20kanswers
220users

pancreatitis

Page 2 of 2 · 30 questions tagged pancreatitis.

30 questions · sorted by votes · page 2 of 2

10 votes0 answers2k views
When does nausea stop being a tolerability issue and become a clinical one?

I would rather spend on verification than on volume. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan…

harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
nausea
nausea

The dominant tolerability signal in every trial of the class: incidence, timing relative to a dose step, duration, and the distinction between…

55 questions
pancreatitis
pancreatitis

Acute pancreatitis as a labelled risk: background incidence, the signal in pooled trial and pharmacovigilance data, lipase interpretation, and the…

30 questions
asked by juliette_farnese 13k · 9 months ago
8 votes 3 answers12k views
When does headache stop being a tolerability issue and become a clinical one?

This is a first order from this supplier, so I have no track record to reason from. The failure mode I am trying to avoid is making this decision emotionally. I have…

harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
pancreatitis
pancreatitis

Acute pancreatitis as a labelled risk: background incidence, the signal in pooled trial and pharmacovigilance data, lipase interpretation, and the…

30 questions
asked by ilaria_bertone 33k · 23 months ago
8 votes 5 answers6.8k views
When does reflux stop being a tolerability issue and become a clinical one?

I have kept every message, invoice and document, which I gather is the useful habit. I am at the decision point and I would rather think it through than improvise. I…

harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
gi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

162 questions
pancreatitis
pancreatitis

Acute pancreatitis as a labelled risk: background incidence, the signal in pooled trial and pharmacovigilance data, lipase interpretation, and the…

30 questions
asked by syringe_ninety 12k · 6 months ago
5 votes 5 answers4.2k views
Is a rising lipase without symptoms actionable?

For the avoidance of doubt, nothing here is urgent — I would be in a clinic rather than a text box. The failure mode I am trying to avoid is making this decision…

pancreatitis
pancreatitis

Acute pancreatitis as a labelled risk: background incidence, the signal in pooled trial and pharmacovigilance data, lipase interpretation, and the…

30 questions
bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
asked by a_lindgren 58k · 6 months ago
4 votes4 answers19k views
Is potassium a better monitoring choice than lipase on a GLP-1 receptor agonist?

For reference: potassium · lipase · a GLP-1 receptor agonist. I am trying to choose between two options that are usually discussed as though only one exists. I am not…

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
kidney-function
kidney-function

eGFR, creatinine, cystatin C and albuminuria: the acute haemodynamic dip that is not injury, the renal outcome data from the FLOW programme, and…

141 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
electrolytes
electrolytes

Sodium, potassium and magnesium during reduced intake and GI losses: what the symptoms of a shortfall look like, when a panel is worth drawing,…

72 questions
pancreatitis
pancreatitis

Acute pancreatitis as a labelled risk: background incidence, the signal in pooled trial and pharmacovigilance data, lipase interpretation, and the…

30 questions
asked by lukas_sedlacek 16k · 23 months ago
3 votes5 answers3.5k views
When does early satiety stop being a tolerability issue and become a clinical one?

I am comparing three suppliers on documentation rather than on price. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real…

harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
gi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

162 questions
pancreatitis
pancreatitis

Acute pancreatitis as a labelled risk: background incidence, the signal in pooled trial and pharmacovigilance data, lipase interpretation, and the…

30 questions
asked by n_takahashi 29k · 14 days ago